NDAORALTABLET
Approved
Jul 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
LO/OVRAL FE (ethinyl estradiol; levonorgestrel; ferrous fumarate) by Cadence Neuroscience is ovulation. First approved in 1979.
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LO/OVRAL FE is an oral contraceptive tablet combining ethinyl estradiol and levonorgestrel to prevent ovulation, with added ferrous fumarate to support iron levels during menstrual cycles. It is a combination hormonal birth control product indicated for contraception in women of reproductive age. The mechanism works by suppressing the LH surge required for ovulation.
LOE Approaching
With LOE approaching and competitive pressure at 30%, expect portfolio transition planning and potential team restructuring or reallocation to other contraceptive assets.
Mechanism of Action
ovulation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LO/OVRAL FE offers limited growth trajectory given its approaching LOE status and zero linked job openings, making it a consolidation or wind-down assignment rather than a career accelerator. Professionals should expect focus on margin protection, generic transition management, and potential portfolio reallocation.
Brand ManagerField Sales Representative
Worked on LO/OVRAL FE at Cadence Neuroscience? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.